CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 78,112	$ 40,540
Restricted cash	15,904	13,593
Patient accounts receivable	319,580	296,785
Prepaid expenses	20,534	11,628
Other current assets	33,097	26,415
Total current assets	467,227	388,961
Property and equipment, net of accumulated depreciation of $93,909 and $101,364	39,631	16,026
Operating lease right of use assets	87,834	102,856
Goodwill	1,244,679	1,287,399
Intangible assets, net of accumulated amortization of $12,838 and $14,604	103,634	101,167
Other assets	84,412	79,836
Total assets	2,027,417	1,976,245
Current liabilities:
Accounts payable	34,555	43,735
Payroll and employee benefits	126,989	125,387
Accrued expenses	139,100	137,390
Termination fee paid by UnitedHealth Group	106,000	0
Current portion of long-term obligations	35,364	15,496
Current portion of operating lease liabilities	26,111	33,521
Total current liabilities	468,119	355,529
Long-term obligations, less current portion	366,853	419,420
Operating lease liabilities, less current portion	61,878	69,504
Deferred income tax liabilities	35,398	20,411
Other long-term obligations	1,651	4,808
Total liabilities	933,899	869,672
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,065,853 and 37,891,186 shares issued; 32,633,599 and 32,511,465 shares outstanding	38	38
Additional paid-in capital	776,880	755,063
Treasury stock, at cost, 5,432,254 and 5,379,721 shares of common stock	(465,613)	(461,200)
Retained earnings	728,603	757,672
Total Amedisys, Inc. stockholders’ equity	1,039,908	1,051,573
Noncontrolling interests	53,610	55,000
Total equity	1,093,518	1,106,573
Total liabilities and equity	$ 2,027,417	$ 1,976,245